Meridian Biosciences, Incorporated
3471 River Hills Drive Cincinnati, OH 45244
Phone: (513) 271-3700
Web Site: www.meridianbioscience.com
Industry: Drugs Sector: Healthcare
Employees: 402
Stock Symbol: MLAB

Business Summary: Meridian Biosciences Inc. is a fully-integrated life science company whose principal businesses are the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases, the manufacture and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers and the contract manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. By exploiting revenue opportunities across research, clinical diagnostics, and therapeutic areas for key biologicals, Meridian can maximize revenues, efficiently invest in research and development, and increase profitability of manufacturing operations. Meridian's reportable operating segments are US Diagnostics, European Diagnostics, and Life Science. The US Diagnostics operating segment's business focuses on the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases. The US Diagnostics operating segment's sales and distribution network consists of a direct sales force in the US and independent distributors in the US and abroad. Meridian's product offering consists of over 200 medical diagnostic products. Meridian's product technologies include enzyme immunoassay, immunofluorescence, particle agglutination/aggregation, immunodiffusion, complement fixation and chemical stains. The US Diagnostics operating segment consists of manufacturing operations in Cincinnati, Ohio, and the sale and distribution of diagnostic test kits in the US and countries outside of Europe, Africa and the Middle East. As of September 30, 2005, the US Diagnostics operating segment had 245 employees. The European Diagnostics operating segment's business focuses on the sale and distribution of diagnostic test kits, those manufactured by the US Diagnostics operating segment and others manufactured by third-party vendors. The European Diagnostics operating segment's sales and distribution network consists of direct sales forces in Belgium, France, Holland, and Italy, and independent distributors in other European countries, Africa and the Middle East. The European Diagnostics operating segment maintains a distribution center in Milan, Italy. The primary markets and customers for this operating segment are hospitals and laboratories. As of September 30, 2005, the European Diagnostics operating segment had 37 employees, including 15 employees in the direct sales force. The Life Science operating segment's business focuses on the development, manufacture, sale, and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic companies, as well as the contract manufacturing of proteins and other biologicals used by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Life Science operating segment consists of manufacturing operations in Memphis, Tennessee; Saco, Maine; and Boca Raton, Florida; the sale and distribution of bulk antigens, antibodies and bioresearch reagents domestically and abroad; and contract research and development and manufacturing services. The Life Science operating segment consists of Meridian's Viral Antigens, BIODESIGN and OEM Concepts businesses. As of September 30, 2005, the Life Science operating segment had 108 employees. Officers: William J. Motto , CEO